ABBOTT, GOOGLE TEAM ON AI GLUCOSE MONITORING

The partnership combines Abbott's expertise in continuous glucose monitoring with Google Health's AI capabilities. The companies will work to enhance glucose prediction accuracy and reduce false alarms in existing monitoring systems. Google Health has been expanding its medical technology initiatives, though recent scrutiny has emerged around researcher participation in past AI projects. Abbott, a leader in diabetes care devices, brings established relationships with patients and healthcare providers. The collaboration is expected to leverage machine learning to identify glucose patterns and predict trends before they occur. This could allow users to proactively manage blood sugar levels with greater precision. Details on timeline, regulatory pathways, and which Abbott devices will be integrated remain limited. Both companies indicated the effort reflects broader industry movement toward AI-assisted healthcare solutions for chronic disease management.